伟志控股(01305.HK)拟590万美元收购半导体设备
格隆汇11月11日丨伟志控股(01305.HK)发布公告,于2020年11月11日,公司间接全资持有的附属公司伟志惠州与卖方Victoria Ultra Business Co., Ltd.订立该协议,据此,伟志惠州有条件同意收购该设备,现金代价为约590万美元。建议收购事项如经落实,集团可开展半导体内存芯片测试和封装业务。
设备主要包括上片机;焊线机器;记忆卡处理相关设备;电射切割和刻字机器;及其他内存芯片封装和测试设备,主要用来支援及令集团有能力推行半导体内存芯片测试及封装业务。
董事认为,建议收购事项如能落实,将令集团有能力推出与SLC及MLC芯片相关的测试及封装业务,并拓阔集团的收入来源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.